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Introduction
Hepatitis B (HB) virus (HBV) infection has generally been used 
to test the infection-atherosclerosis hypothesis due to several of 
its characteristics.
1-3 For example, HBV can cause immune re-
sponses and may colonize the vascular tissues. In addition, it 
can cause thrombotic states, such as obliteration of the small 
portal and hepatic veins due to phlebitis and thrombosis asso-
ciated with the disease progression.
3,4 However, despite these 
characteristics, it has been recognized that the findings regard-
ing the association between HBV infection and atherosclerosis 
are conflicting. Furthermore, because previous studies have usu-
ally been based on the general population, it is not yet known 
how atherosclerosis or ischemic stroke is related to HBV in-
fection.
5,6
We describe herein a case of multiple cerebral arterial steno-
ses associated with HBV infection, and discuss the role of HBV 
infection in the development of atherosclerosis.
Case Report
A 34-year-old man was admitted to our tertiary hospital for tran-
sient dysarthria and facial weakness. He had experienced 
slurred speech, left facial weakness, and dizziness for several 
hours. His symptoms had completely recovered and he had 
no neurological abnormalities at admission. There were no vas-
cular risk factors including hypertension, diabetes, hyperlip-
idemia, smoking, alcohol drinking, or a family history of vas-
cular diseases. Ten years previously this patient had been dia-
gnosed with HBV infection and treated with lamivudine (100 
mg/day) at a local clinic. Six months before admission to our 
hospital he had suffered abdominal discomfort, nausea, and 
fatigue, at which time reactivation of HBV was detected. He 
was seropositive for HB early antigen (Ag) and HB surface 
(HBs) Ag, antibodies against these Ags, and HB core antibod-
ies. Thereafter, the treatment was changed from lamivudine 
to entecavir (1 mg/day). Serologic tests performed in our hos-
pital revealed that this patient remained positive for HB early 
Ag, HBs Ag, and HB core antibodies. Findings of laboratory 
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tests including cholesterol profiles, C-reactive protein, D-di-
mer, fibrin degradation product, Venereal Disease Research 
Laboratory test, Helicobacter pylori Ag (enzyme-linked immu-
nosorbent assay), and immunoglobulin M of Chlamydia pneu-
monia were normal. Screening tests for autoimmune and coag-
ulation diseases including erythrocyte sedimentation rate, an-
tinuclear antibody, anticardiolipin antibody, rheumatoid factor, 
lupus anticoagulant, anti-dsDNA, anti-Ro, anti-La, anti-neu-
trophilic cytoplasmic antibody, C3, C4, prothrombin time, ac-
tivated partial thromboplastin time, protein-C, protein-S, and 
antithrombin-III also produced normal results. Brain magnetic 
resonance (MR) images were normal, but MR angiograms re-
vealed severe stenosis of the right middle cerebral artery, both 
external carotid arteries, and the basilar artery. Conventional 
cerebral angiograms also demonstrated that the patient had ec-
centric and irregular stenoses in the same arteries (Fig. 1). Ab-
dominal and aortic angiograms for differential diagnosis of vas-
culitis such as Takayasu’s arteritis, fibromuscular dysplasia, 
and/or polyarteritis nodosa (PAN) yielded normal findings. Ar-
terial stiffness was slightly higher compared to the norm for 
healthy men aged 34 years. The patient was treated with meth-
ylprednisolone (500 mg/day for 5 days, then tapered and stopp-
ed), entecavir (1 mg/day), and combined antiplatelet medica-
tion (aspirin and clopidogrel). Although transcranial Doppler 
performed 6 months later revealed that there was no improve-
ment in flow velocity at the stenotic arteries, the patient had not 
developed any ischemic symptoms.
Discussion
This case report reveals that multiple intracranial arterial steno-
ses were observed in association with HBV reactivation in a 
young patient without conventional vascular risk factors. The 
patterns of arterial stenosis and collateral supplies suggested 
that arterial stenoses develop due to long-standing atheroscle-
rosis. There have been no reports about intracranial arterial ste-
nosis and/or multiple cerebral arterial stenosis associated with 
HBV infection in young adults. One possible differential diag-
nosis in this case could be reversible cerebral vasoconstriction 
syndrome. This patient had been taking an antiviral agent when 
he developed neurological symptoms, which makes antiviral-
drug-induced vasculitis a possible cause of this case. Howev-
er, follow-up transcranial Doppler revealed that there was no 
improvement of flow velocity following appropriate treatment. 
Furthermore, atherosclerosis is usually shown to be eccentric 
and irregular stenosis.
7 Our patient had eccentric and irregular 
stenosis of the middle cerebral artery and basilar artery, and so 
his atherosclerosis may have been caused by chronic and reac-
tivated HBV infection.
We presumed that HBV had recently reactivated and played 
a role in the progression and destabilization of atherosclerotic 
plaques in multiple cerebral arteries. Several possible mecha-
nisms could explain the relationship between HBV infection 
and atherosclerosis. First, because HBV is an intracellular or-
ganism, it may invade the vascular system.
2,8 In order to con-
firm this hypothesis, pathologic studies that were not available 
for this case should be performed. Second, HBV infection has 
occasionally been associated with vasculitis. A substantial pro-
portion of cases of PAN are related to HBV infection.
9,10 How-
ever, in our case there was no evidence of either PAN or any 
other vasculitis. Finally, chronic HBV infection may stimulate 
inflammatory and immune-mediated responses.
11 There was no 
laboratory evidence in our patient of an immune-mediated re-
sponse, such as an elevated erythrocyte sedimentation rate. How-
ever, because reactivation of HBV infection started 6 months 
before admission to our hospital, this is a possible mechanism 
LCCA RCCA A   B   C  
Fig. 1. Conventional cerebral angiogram. A: Right carotid angiogram showing severe focal stenosis in the midportion of the middle cerebral 
artery (arrows) that is eccentric and irregular. B: Carotid angiogram showing stenosis of both external carotid arteries (dotted arrows). C: 
Right vertebral arteriogram showing severe stenosis of the proximal basilar artery and left distal vertebral artery (arrows).Arterial Stenosis Associated with HBV Infection
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underlying the development of multiple arterial stenoses. The 
clinical course of chronic HBV infection is characterized by a 
series of exacerbations and remissions. Our patient with multi-
ple arterial stenoses presented with transient dysarthria and fa-
cial palsy during the reactivation of HBV. Although no baseline 
MR images were acquired before the HBV reactivation, time-
ly association of the HBV reactivation and the ischemic events 
led us consider a possible pathogenic link.
Previous studies have shown that certain infectious agents 
play an important role in atherogenesis.
12,13 However, it is un-
clear whether atherogenesis is associated with any infection 
that provokes activation of inflammatory processes or whether 
only specific organisms play an important role. In addition, 
some investigators have reported that the activation of an in-
flammatory process, rather than specific infectious agents, 
might be responsible for the development of atherosclerotic 
diseases.
14,15 Ishizaka et al.
5 recently investigated the possible 
association between HBs Ag positivity and carotid arterioscle-
rosis. In contrast, Kiechl et al.
14 found no significant association 
between chronic hepatitis and the presence of carotid athero-
matous plaques, but it has also been shown that HBV infection 
has several features that make it potentially atherogenic.
6 These 
conflicting results
6,14 make large population studies necessary 
for clarification.
In conclusion, we describe herein a patient who developed 
multiple cerebral arterial stenoses associated with HBV infec-
tion. This case suggests that patients with HBV infection can 
develop multiple cerebral arterial stenoses even though they 
have no risk factors for this disease. However, because there are 
some conflicting findings, further studies are needed to confirm 
the association between HBV infection and atherosclerosis.
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